Delivery Address
Select Address
- Login
Select Address
Pregascreen Dual Marker Reflex Test
The Pregascreen Dual Test (also called First Trimester Serum Dual Marker Test) is a prenatal screening test done in the first trimester (between 8 and 13.6 weeks of pregnancy) to assess the chance of fetal chromosomal abnormalities like Down syndrome (Trisomy 21), neural tube defects, Trisomy 18 etc. It measures two substances in the mother’s blood viz. Pregnancy-associated plasma protein-A (PAPP-A) and Free beta-human chorionic gonadotropin (free ß-hCG) and provides a risk assessment. If the initial screening shows a higher-than-average risk, a confirmatory test like Non-Invasive Prenatal Testing (NIPT) or Karyotyping/FISH of chorionic villus sampling (CVS) is recommended for a more precise diagnosis.
The TruHealth Cancer Screen 360 Male package includes cancer screening tests for males such as PSA for prostate cancer, hereditary cancer risk genetic analysis, and gender-specific screening modules for common male cancers.
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.
₹3,600.00
Book any blood test or health checkup and get tested at the comfort of your home
Pregascreen Dual Marker Reflex Test
The Pregascreen Dual Test (also called First Trimester Serum Dual Marker Test) is a prenatal screening test done in the first trimester (between 8 and 13.6 weeks of pregnancy) to assess the chance of fetal chromosomal abnormalities like Down syndrome (Trisomy 21), neural tube defects, Trisomy 18 etc. It measures two substances in the mother’s blood viz. Pregnancy-associated plasma protein-A (PAPP-A) and Free beta-human chorionic gonadotropin (free ß-hCG) and provides a risk assessment. If the initial screening shows a higher-than-average risk, a confirmatory test like Non-Invasive Prenatal Testing (NIPT) or Karyotyping/FISH of chorionic villus sampling (CVS) is recommended for a more precise diagnosis.
The TruHealth Cancer Screen 360 Male package includes cancer screening tests for males such as PSA for prostate cancer, hereditary cancer risk genetic analysis, and gender-specific screening modules for common male cancers.
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.
₹3,600.00
Not sure which tests to take? Share your prescription with us and our team will call you to book tests for you.
